VONSETAMIG

UNII:	30WLL6DR9O
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	VONSETAMIG
GSRS Full Record:	30WLL6DR9O i

2408319-33-3
Immunoglobulin G4 [103-cysteine,108-cysteine,233-proline,238-proline,239-valine,240-alanine,de-241-glycine], anti-(human B-cell maturation antigen) (human monoclonal REGN5459 γ4-chain), disulfide with human monoclonal REGN5459 κ-chain, (231→230′),(234→233′)-bis(disulfide) with immunoglobulin G4 [232-proline,237-proline,238-valine,239-alanine,de-240-glycine,439-arginine,440-phenylalanine,449-proline] anti-(human CD3 antigen) (human monoclonal REGN5459 γ4-chain) disulfide with human monoclonal REGN5459 κ-chain
Immunoglobulin G4-kappa, anti-[Homo sapiens TNFRSF17 (TNF receptor superfamily member 17, BCMA, TNFRSF13A, CD269) and CD3E (CD3 epsilon)], Homo sapiens monoclonal antibody, bispecific, bivalent
Vonsetamig
vonsetamig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VONSETAMIG

Synonyms and Mappings

Resources